Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.24.1.1.u2
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Our Financial Assets and Liabilities The following table summarizes the fair value of our financial assets and liabilities that were accounted for at fair value on a recurring basis, by level within the fair value hierarchy:
    March 31, 2024  
    Level 1     Level 2         Level 3     Fair Value  
Assets:                        
Cash equivalents:                        
Money market funds     37,124      
-
     
-
      37,124  
Foreign exchange contracts receivable             99      
-
      99  
      37,124       99      
-
      37,223  
Liabilities:                                
Contingent consideration                     153       153  
Private Placement Warrants                     36,755       36,755  
      -               36,908       36,908  
   

 

 

December 31, 2023

 
    Level 1     Level 2      Level 3       Fair Value  
Assets:                        
Cash equivalents:                        
Money market funds     11,377      
-
     
-
      11,377  
Foreign exchange contracts receivable             256      
-
      256  
      11,377       256      
-
      11,633  
Liabilities:                                
Contingent consideration    
-
     
-
      155       155  
     
-
     
-
      155       155  
Schedule of Fair Value Level 3 financial liabilities The changes in the fair value of the Company’s Level 3 financial liabilities, which are measured on a recurring basis are as follows:
    Three Months Ended
March 31,
2024
    Three Months Ended
March 31,
2023
 
Beginning balance  
-
   
-
 
Private Placement Warrants     28,745      
        -
 
Revaluation recorded in financial expense     8,010      
-
 
Ending balance     36,755      
-
 
Schedule of Fair Value of the Liabilities for the Private Placement Warrants The main assumptions used are as follows:
    Three Months Ended
March 31,
 
    2024     2023  
Underlying value of Common Stock ($)     0.37-0.45       -  
Exercise price ($)     0.23       -  
Expected volatility (%)     117.7-117.8       -  
Expected terms (years)     2.3-2.25       -  
Risk-free interest rate (%)     4.5-4.6       -